Cargando…

Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery

BACKGROUND: Although sentinel lymph node (SLN) biopsy is a standard of care for the evaluation of the axillary lymph nodes during breast cancer surgery, a substantial degree of variation exists among individual surgeons as to what represents an adequate assessment. The aim of the current study was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Povoski, Stephen P, Young, Donn C, Walker, Michael J, Carson, William E, Yee, Lisa D, Agnese, Doreen M, Farrar, William B
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797807/
https://www.ncbi.nlm.nih.gov/pubmed/17291336
http://dx.doi.org/10.1186/1477-7819-5-18
_version_ 1782132314878246912
author Povoski, Stephen P
Young, Donn C
Walker, Michael J
Carson, William E
Yee, Lisa D
Agnese, Doreen M
Farrar, William B
author_facet Povoski, Stephen P
Young, Donn C
Walker, Michael J
Carson, William E
Yee, Lisa D
Agnese, Doreen M
Farrar, William B
author_sort Povoski, Stephen P
collection PubMed
description BACKGROUND: Although sentinel lymph node (SLN) biopsy is a standard of care for the evaluation of the axillary lymph nodes during breast cancer surgery, a substantial degree of variation exists among individual surgeons as to what represents an adequate assessment. The aim of the current study was to assess when metastatic disease was first identified within consecutively harvested SLN candidates for invasive breast cancers demonstrating a positive SLN. METHODS: We retrospectively analyzed a series of 400 breast cancers from a recently published prospective randomized clinical trial. A combined radiocolloid and blue dye technique was used. All potential SLN candidates, containing counts of at least 10% of the hottest SLN and/or containing blue dye, were harvested and were consecutively numbered in the order of the decreasing level of counts (with the hottest SLN representing SLN #1). RESULTS: Among 371 invasive breast cancers, a SLN was identified within 353 cases (95%). Mean number of SLNs identified was 2.5 (range, 1 to 9), with a single SLN identified in 104 (29%) cases, two identified in 110 (31%), three identified in 73 (21%), four identified in 35 (10%), five identified in 16 (5%), and six or more identified in 15 (4%). A positive SLN was found in 104 (29%) cases. SLN #1 was the first positive SLN in 86 (83%). SLN #2 was the first positive SLN in 15 (14%). SLN #3, SLN #4, and SLN #5 were the first positive SLN in one case (1%) each. A positive SLN was found in 18% (19/104) of cases when a single SLN was identified, as compared to in 34% (85/249) when two or more SLNs were identified (P = 0.003). CONCLUSION: The accurate and optimal assessment of the axilla during breast cancer surgery requires persistence and diligence for attempting to identify all potential SLN candidates in order to avoid failing to recognize a positive SLN. The scenario in which only a single negative SLN candidate is intraoperatively identified is one that should raise some concern to the operating surgeon.
format Text
id pubmed-1797807
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-17978072007-02-15 Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery Povoski, Stephen P Young, Donn C Walker, Michael J Carson, William E Yee, Lisa D Agnese, Doreen M Farrar, William B World J Surg Oncol Research BACKGROUND: Although sentinel lymph node (SLN) biopsy is a standard of care for the evaluation of the axillary lymph nodes during breast cancer surgery, a substantial degree of variation exists among individual surgeons as to what represents an adequate assessment. The aim of the current study was to assess when metastatic disease was first identified within consecutively harvested SLN candidates for invasive breast cancers demonstrating a positive SLN. METHODS: We retrospectively analyzed a series of 400 breast cancers from a recently published prospective randomized clinical trial. A combined radiocolloid and blue dye technique was used. All potential SLN candidates, containing counts of at least 10% of the hottest SLN and/or containing blue dye, were harvested and were consecutively numbered in the order of the decreasing level of counts (with the hottest SLN representing SLN #1). RESULTS: Among 371 invasive breast cancers, a SLN was identified within 353 cases (95%). Mean number of SLNs identified was 2.5 (range, 1 to 9), with a single SLN identified in 104 (29%) cases, two identified in 110 (31%), three identified in 73 (21%), four identified in 35 (10%), five identified in 16 (5%), and six or more identified in 15 (4%). A positive SLN was found in 104 (29%) cases. SLN #1 was the first positive SLN in 86 (83%). SLN #2 was the first positive SLN in 15 (14%). SLN #3, SLN #4, and SLN #5 were the first positive SLN in one case (1%) each. A positive SLN was found in 18% (19/104) of cases when a single SLN was identified, as compared to in 34% (85/249) when two or more SLNs were identified (P = 0.003). CONCLUSION: The accurate and optimal assessment of the axilla during breast cancer surgery requires persistence and diligence for attempting to identify all potential SLN candidates in order to avoid failing to recognize a positive SLN. The scenario in which only a single negative SLN candidate is intraoperatively identified is one that should raise some concern to the operating surgeon. BioMed Central 2007-02-09 /pmc/articles/PMC1797807/ /pubmed/17291336 http://dx.doi.org/10.1186/1477-7819-5-18 Text en Copyright © 2007 Povoski et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Povoski, Stephen P
Young, Donn C
Walker, Michael J
Carson, William E
Yee, Lisa D
Agnese, Doreen M
Farrar, William B
Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery
title Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery
title_full Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery
title_fullStr Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery
title_full_unstemmed Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery
title_short Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery
title_sort re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797807/
https://www.ncbi.nlm.nih.gov/pubmed/17291336
http://dx.doi.org/10.1186/1477-7819-5-18
work_keys_str_mv AT povoskistephenp reemphasizingtheconceptofadequacyofintraoperativeassessmentoftheaxillarysentinellymphnodesforidentifyingnodalpositivityduringbreastcancersurgery
AT youngdonnc reemphasizingtheconceptofadequacyofintraoperativeassessmentoftheaxillarysentinellymphnodesforidentifyingnodalpositivityduringbreastcancersurgery
AT walkermichaelj reemphasizingtheconceptofadequacyofintraoperativeassessmentoftheaxillarysentinellymphnodesforidentifyingnodalpositivityduringbreastcancersurgery
AT carsonwilliame reemphasizingtheconceptofadequacyofintraoperativeassessmentoftheaxillarysentinellymphnodesforidentifyingnodalpositivityduringbreastcancersurgery
AT yeelisad reemphasizingtheconceptofadequacyofintraoperativeassessmentoftheaxillarysentinellymphnodesforidentifyingnodalpositivityduringbreastcancersurgery
AT agnesedoreenm reemphasizingtheconceptofadequacyofintraoperativeassessmentoftheaxillarysentinellymphnodesforidentifyingnodalpositivityduringbreastcancersurgery
AT farrarwilliamb reemphasizingtheconceptofadequacyofintraoperativeassessmentoftheaxillarysentinellymphnodesforidentifyingnodalpositivityduringbreastcancersurgery